Sign in
Taking people in United KingdomNo phase

Why some people with normal pressure hydrocephalus do not improve after shunt surgery

Studies brain nerve pathways and dementia markers in older adults with normal pressure hydrocephalus.

Key facts

Who runs it
Imperial College London
Where
London, United KingdomSee the site
Trial code
Registry title
White Matter Distortion and Dementia Biomarkers in Normal Pressure Hydrocephalus (NPH)
Status
Recruiting
People taking part
100 people, planned
Started
25 Mar 2025
Expected to end
Feb 2029
Type of study
Observational, 2 groups
Treatments tested
  • Ventriculoperitoneal Shunt (VP)
  • Brain and Skin Biopsy
  • MRI Brain
Record updated
27 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults over 60 with normal pressure hydrocephalus (extra fluid in the brain) who may have shunt surgery. It also takes a comparison group: people with other dementias, hydrocephalus without symptoms, and healthy people.

Age
Group 1: over 60. Minimum age 60 Years.
Sex
All sexes can join.
Disease stage
Group 1: communicating hydrocephalus with walking problems (gait apraxia) and bladder problems, with or without memory or thinking problems. Group 2: healthy carers, members of the public, Imperial College/ICHT staff, people with non-NPH dementia (such as Alzheimer's disease or vascular dementia), or hydrocephalus without symptoms.
Biomarker or test result
Group 1: brain imaging with an Evan's index >0.3 and an iNPH Radscale score >4.

Main reasons for not taking part

  • Group 1: high-pressure hydrocephalus, or hydrocephalus without symptoms
  • Group 1: serious head injury within 5 years, or a clear other cause such as brain infection
  • Group 1: another clear cause of symptoms, such as Parkinson's disease, nerve damage or a neck spinal cord problem
  • Group 1: too frail for shunt surgery, medically unstable, unable to move, or unable to have an MRI or lumbar puncture
  • Anyone unable to come to the hospital for study visits

The registry criteria, word for word

Show all 23 criteriaShow less

Who can take part

  • Adult patients >60
  • With gait apraxia
  • With or without cognitive impairment
  • Urinary dysfunction
  • Communicating Hydrocephalus
  • Healthy Carers
  • Members of the Public
  • Staff of Imperial College/ICHT
  • Non-NPH Dementias (including Alzheimer's disease or vascular dementia)
  • Asymptomatic Hydrocephalus

Who cannot take part

  • Too frail for shunt surgery
  • Serious head injury within 5 years of presentation or a clear secondary cause (e.g. brain infection)
  • History of childhood gait disturbance
  • Clear alternative explanation for symptoms (e.g. Parkinson's disease with limb rigidity, peripheral neuropathy with sensory ataxia, cervical myelopathy)
  • Medically unstable (e.g. active angina, respiratory disease, recurrent delirium, active epilepsy)
  • Unable to attend the hospital for study visits; Group 2 (asymptomatic and non-hydrocepahlus dementia and healthy controls):
  • Asymptomatic hydrocephalus
  • High pressure-hydrocephalus
  • Unable to tolerate MRI brain imaging
  • Unable to have a lumbar puncture
  • Immobile
  • Unable to attend the hospital for study visits

Other criteria

  • Group 1 (communicating hydrocephalus):

Where in United Kingdom

  • Imperial College Healthcare NHS TrustLondon, United KingdomContact: Chris Carswell, PHD, FRCPTaking people

About the trial

What the trial wants to find out

Idiopathic Normal Pressure Hydrocephalus (iNPH) is a progressive condition of the elderly that results in severe disability. iNPH can dramatically respond to Cerebral spinal fluid(CSF)-shunting where excess ventricular fluid is diverted from the brain. Not all patients with iNPH respond to CSF-shunting however. The reasons for this are uncertain.

Read full original descriptionShow less

Aim 1: To understand if specific nerve pathways (white matter tracts) that are near ventricles are damaged in patients that respond to shunting as opposed to those that do not.

Aim 2: Can we explain shunt non-responsiveness by screening for dementia like illnesses (neurodegeneration) using a large array of methods.

Aim 3: To understand whether wearable activity and bed sleep monitors are palatable in a NPH population and to understand if these metrics relate to quality of life.

Aim 4: To see whether self-administered digital cognitive assessments can measure improvements pre and post surgery.

The 2 groups in the trial

  • Group 1

    Group 1 includes adults over 60 years old diagnosed with late-onset communicating hydrocephalus, characterised by gait apraxia, with or without cognitive impairment and urinary dysfunction. Eligibility is confirmed through clinical imaging showing an Evan's index \>0.3 and an iNPH Radscale score \>4. Individuals with recent severe head trauma, high-pressure hydrocephalus, or alternative causes for similar symptoms are excluded. This criteria for group 1 ensures a distinct group for studying the late-onset, communicating form of the condition.

    Treatment: Ventriculoperitoneal Shunt (VP), Brain and Skin Biopsy, and MRI Brain

  • Group 2

    Group 2 will include 30 adult patients with asymptomatic chronic hydrocephalus, non-hydrocephalus dementia and healthy controls.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Observational Study to Investigate the Effect of White Matter Tract Distortion and Neurodegenerative Biomarkers on Shunt-responsiveness in Idiopathic Normal Pressure Hydrocephalus (iNPH)
Plain-language title
Why some people with normal pressure hydrocephalus do not improve after shunt surgeryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
27 March 2026